Cargando…
Discovery of novel benzylquinazoline molecules as p97/VCP inhibitors
Introduction: Protein p97 is an extensively investigated AAA ATPase with various cellular activities, including cell cycle control, ubiquitin–proteasome system, autophagy, and NF-κB activation. Method: In this study, we designed, synthesized and evaluated eight novel DBeQanalogs as potential p97 inh...
Autores principales: | Zhang, Xiaoyi, Jiang, Lingna, Li, Yixin, Feng, Qiqi, Sun, Xiulin, Wang, Yaonan, Zhao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300352/ https://www.ncbi.nlm.nih.gov/pubmed/37388451 http://dx.doi.org/10.3389/fphar.2023.1209060 |
Ejemplares similares
-
Synthesis and In Vitro Evaluation
of 2-[3-(2-Aminoethyl)-1H-indol-1-yl]-N-benzylquinazolin-4-amine as a Novel p97/VCP Inhibitor
Lead Capable of Inducing Apoptosis in Cancer Cells
por: Feng, Qiqi, et al.
Publicado: (2020) -
P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration
por: Wang, F, et al.
Publicado: (2022) -
Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants
por: Zhang, Ting, et al.
Publicado: (2017) -
VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
por: Cheng, Cheng, et al.
Publicado: (2022) -
Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2017)